Unknown OBSERVATIONAL NCT01777451

Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis (NEFIMAR)

Sponsor: Universitaire Ziekenhuizen KU Leuven

Conditions Diffusion Magnetic Resonance Imaging Magnetic Resonance Imaging Neurofibromatosis 1 Peripheral Nerve Sheath Tumors, Malignant Whole Body Imaging

Interventions Additional imaging or surgery

Updated 6 times since 2017 Last updated: Jan 23, 2013 Started: Dec 31, 2010 Primary completion: Jan 31, 2013 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01777451, this observational or N/A phase trial focuses on Diffusion Magnetic Resonance Imaging and Magnetic Resonance Imaging and remains ongoing. Sponsored by Universitaire Ziekenhuizen KU Leuven, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Nov 2022 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitaire Ziekenhuizen KU Leuven

Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium